Pharma News
Pharmaceutical
USA-based Sentynl Therapeutics and Mereo BioPharma Group have entered into an option and license agreement for the US commercial and global manufacturing rights to alvelestat for alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). 12 August 2026
Pharmaceutical
Donald Trump signed an executive order on Monday recommending that American children be routinely immunized against 11 diseases rather than the 18 covered by the US Centers for Disease Control and Prevention's (CDC) 2024 schedule, and that the combined measles, mumps and rubella (MMR) vaccine be split into three single-disease shots. 11 August 2026
Pharmaceutical
The US Food and Drug Administration has approved Japanese pharma major Takeda’s Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults. The company’s shares rose 3% to 5,425 yen on the news. 6 August 2026
Most Read
Recent news
Pharmaceutical
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Romvimza (vimseltinib) to treat adult patients with enosynovial giant cell tumor (TGCT) when it impacts movement or where surgery is not an option. 14 August 2026
Pharmaceutical
The Russian subsidiary of the Indian pharmaceutical company Dr Reddy's Laboratories received the rights to three gynecological drugs from the local drugmaker Vertex with the aim to significantly strengthen its presence in that segment of the market, reports The Pharma Letter’s local correspondent. 14 August 2026
Pharmaceutical
The number of new cancer drugs are being launched in the Russian market is steadily declining these days, which is mainly due to the drop of local demand for them and tough business environment in Russia at present. 14 August 2026
Pharmaceutical
The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb’s Zenbexus (iberdomide) in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd) for the treatment of adult patients with multiple myeloma who have received at least one prior line of therapy including a proteasome inhibitor and an immunomodulatory agent. 14 August 2026
Pharmaceutical
Danish allergy immunotherapy specialist ALK Abello today announced that the UK’s National Institute for Health and Care Excellence (NICE) has recommended two sublingual immunotherapy tablets for the treatment of moderate to severe allergic rhinitis in children whose symptoms are not controlled by symptomatic treatments. 14 August 2026
Refine search
In Brief
Pharmaceutical
6 August 2026 There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a potential deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted mega merger between the drugmakers.
Pharmaceutical
7 July 2026 Codis has agreed to acquire Catalent Pharma Solutions’ Nottingham, UK, facility, expanding its contract development and manufacturing organization (CDMO) capabilities in oral solid dose development and manufacturing. The deal is expected to close in the third quarter of 2026, subject to customary conditions.
Insights
Pharmaceutical
An Expert View from Ella Green, Maggie Gisseleire, and Laura Johnson, Carpmaels & Ransford. 7 August 2026
Pharmaceutical
Russia is considering increasing drug procurements against hepatitis C. According to official data, governmental procurements of such drugs over the last year and a half has reached almost 50 billion roubles ($619.2 million), reports The Pharma Letter’s local correspondent. 5 August 2026
Pharmaceutical
In July 2025 the White House sent letters to 17 large drugmakers asking them to match, for American patients, the lowest prices they charge in other wealthy nations. A year on, all 17 have signed "most-favored-nation" (MFN) pricing deals. The administration says the group accounts for about 86% of the branded US market. 4 August 2026
Pharmaceutical
India’s pharmaceutical sector is undergoing a structural shift, with diabetes therapies and cardiac care driving growth well above the broader market. 3 August 2026
Pharmaceutical
Medicines regulators recorded a relatively quiet week in the seven days to 3 August 2026, with the USA accounting for the confirmed activity. 3 August 2026
Pharmaceutical
Russia is experiencing a boom of sales of drugs for sexual health, which are growing at double-digit rates these days, reports The Pharma Letter’s local correspondent. 27 July 2026
Pharmaceutical
India’s mergers and acquisitions (M&A) market hit a four-year high in the April to June quarter, powered by a single blockbuster: Sun Pharmaceutical Industries' $11.75 billion acquisition of Organon & Co. 25 July 2026
Boardroom
Pharmaceutical
Pace, a science and technology company, has appointed Andrew (Andy) Fenny as president of Pace Life Sciences, the organization’s life sciences division, to lead the business into its next phase of strategic growth with a focus on expanding support and capacity for pharmaceutical and biotech clients across the development cycle. 14 August 2026
Pharmaceutical
US clinical-stage biopharma Kailera Therapeutics, focused on elevating the next era of obesity care, today announced the appointment of Nur Nicholson as chief technology officer (CTO), effective August 31, 2026. 11 August 2026
Pharmaceutical
UK clinical-stage pharma NRG Therapeutics has announced the appointment of Dr Claus Sundgreen as chief medical officer (CMO), effective August 1, 2026. 3 August 2026
Pharmaceutical
US obesity specialist Ambrosia Biosciences has strengthened its clinical and scientific ranks, naming cardiometabolic drug developer Linda Shapiro Manning as chief medical officer and adding obesity researcher Randy Seeley to its scientific advisory board. The privately held Boulder, Colorado firm is preparing to move its lead oral candidate into first human trials. 28 July 2026
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze